Xencor reported $8.86M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.07B 228M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Alnylam Pharmaceuticals ALNY:US $ 153.82M 1.08M
Amgen AMGN:US $ 1.38B 130M
Arrowhead Research ARWR:US $ 17.86M 1.67M
AstraZeneca AZN:LN 2.57B 76M
Biogen BIIB:US $ 654.1M 16.8M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Cytokinetics CYTK:US $ 21.2M 5.6M
Epizyme EPZM:US $ 33.89M 2.52M
GlaxoSmithKline GSK:LN 2.5B 183M
Johnson & Johnson JNJ:US $ 6B 73M
Karyopharm Therapeutics KPTI:US $ 36.53M 1.12M
Macrogenics MGNX:US $ 15.23M 198K
Merk MRK:US $ 2.25B 376M
Novartis NOVN:VX 3.71B 190M
Pfizer PFE:US $ 2.79B 134M
Regeneron Pharmaceuticals REGN:US $ 414.7M 9.1M
Seattle Genetics SGEN:US $ 165.13M 5.29M
Xencor XNCR:US $ 8.86M 637K